IL6 and breast cancer: TAMs also establish an inflammatory milieu via releasing numerous pro-inflammatory cytokines such as CXCL8 in endometrial cancer, IL6 in breast cancer, and IL1β in pancreatic cancer, which ultimately have correlated with poor prognosis (145).